US 7087234
Recombinant multivalent viral vaccine
granted A61KA61K2039/5256A61K2039/70
Quick answer
US patent 7087234 (Recombinant multivalent viral vaccine) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/5256, A61K2039/70